Login / Signup

A spectrophotometric study of the impact of pH and metal-to-ligand ratio on the speciation of the Pu(VI)-oxalate system.

A Kirstin SockwellNicole A DiBlasiAmy E Hixon
Published in: Physical chemistry chemical physics : PCCP (2023)
The oxalate ligand is prevalent throughout the nuclear fuel cycle. While the Pu(III)- and Pu(IV)-oxalate systems are well studied due to their use in plutonium metal and PuO 2 production, the effect of oxalate on Pu(VI) remains understudied. Absorption spectroscopy was employed to probe the solution behavior of the Pu(VI)-oxalate system as a function of pH (1, 3, 7) and metal-to-ligand ratio (M/L; 10 : 1-1 : 10). Peak changes in the UV-vis-NIR spectra were associated with the formation of multiple Pu(VI)-oxalate species with increasing oxalate concentration. Some insight into identification of species present in solution was gained from the limited Pu(VI)-oxalate literature and comparisons with the assumed isostructural U(VI)-oxalate system. A peak in the UV-vis-NIR spectrum at 839 nm, which corresponds to the formation of a 1 : 1 PuO 2 (C 2 O 4 )(aq) complex, was observed and used to determine the formation constant (log  β ° = 4.64 ± 0.06). A higher coordinated Pu(VI)-oxalate peak at 846 nm was tentatively assigned as the 1 : 2 complex PuO 2 (C 2 O 4 ) 2 2- and a preliminary formation constant was determined (log  β ° = 9.30 ± 0.08). The predominance of both complexes was shown in speciation diagrams calculated from the formation constants, illustrating the importance of considering the Pu(VI)-oxalate system in the nuclear fuel cycle.
Keyphrases
  • photodynamic therapy
  • systematic review
  • drug delivery
  • living cells
  • fluorescent probe
  • drug release